Skip to main content

Table 7 Mean difference in clinical and health status measures during exacerbation and after one month of treatment (n = 47)

From: Validation and clinical interpretation of the St George’s respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD

 

Mean Difference (95% CI)

Effect Size

pvalue

SGRQ-CM

 Activity

5.94 (5.29–6.58)

0.47

< 0.001

 Impact

6.05 (5.30–6.80)

0.52

< 0.001

Spirometry Values

 FEV1/FVC

−1.57 (−1.85–1.30)

0.18

< 0.001

 FEV1 (%)

−1.58 (−1.86–1.31)

0.19

< 0.001

  1. Exacerbation Patients n = 47; difference is significant at 0.05 level; FEV1, forced expiratory volume in one second; FVC, Forced vital capacity; FEV1 (%), percentage predicted FEV1; Spirometric data were post-bronchodilator; SGRQ-CM, Malaysian version of St George’s Respiratory COPD specific Questionnaire